Log In
Print
BCIQ
Print
Print this Print this
 

Debio 1142

  Manage Alerts
Collapse Summary General Information
Company Debiopharm Group
DescriptionCancer pathway inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner

Aurigene Discovery Technologies Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today